June 17, 2024
Coronavirus Updates
We are following the latest developments with COVID-19 and the recommendations by the Centers for Disease Control and Prevention.
June 17, 2024
We are following the latest developments with COVID-19 and the recommendations by the Centers for Disease Control and Prevention.
June 17, 2024
Matthew Nielsen, MD, MS, was selected by the National Academy of Medicine to participate in the 2024 class of the NAM Scholars in Diagnostic Excellence program.
June 7, 2024
The American Society of Clinical Oncology and Conquer Cancer recognized UNC Lineberger faculty and trainees at ASCO’s annual meeting.
June 7, 2024
OncLive named Ethan Basch, MD, MSc, FASCO, as one of the 2024 Giants of Cancer Care for his pioneering research in the field of patient-reported outcomes.
June 6, 2024
UNC Lineberger researchers have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene, and how its activities impact pancreatic cancer outcomes.
June 4, 2024
Motivated by concerns about thyroid cancer in several communities in Iredell County, UNC Lineberger researchers have launched a multi-institutional study to investigate thyroid cancer incidence in North Carolina.
June 3, 2024
UNC Lineberger Director Shelley Earp, MD, has been appointed chair of the NCI Board of Scientific Advisors. The board advises the NCI director and program leaders on research priorities.
May 31, 2024
National Cancer Survivors Day is a special day to celebrate loved ones who have experienced cancer or are battling it now.
May 28, 2024
UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the ASCO Annual Meeting.
May 21, 2024
Medical oncologist Jacob Stein, MD, explains what most people can expect from chemotherapy.